Brief: Outlook Therapeutics Requests Type A Meeting With FDA
02/09/2025 17:58
Outlook Therapeutics Inc OTLK.O: OUTLOOK THERAPEUTICS REQUESTS TYPE A MEETING WITH FDA OUTLOOK THERAPEUTICS INC: TYPE A MEETING REQUEST HAS BEEN SUBMITTED TO U.S. FDA TO DISCUSS CRL REGARDING BLA RESUBMISSION FOR ONS-5010 OUTLOOK THERAPEUTICS: REQUESTED TYPE A MEETING SEEKS TO CLARIFY DETAILS OF CONFIRMATORY EVIDENCE REQUIRED BY FDA FOR ONS-5010 Source text: ID:nGNX9ZqXtQ Further company coverage: OTLK.O
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce